Galectin Therapeutics Inc

CHARLES SCHWAB INVESTMENT MANAGEMENT INC GALT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

29,985

Value ($000)

125

Weight

0.0%

2014 Q2 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	125	0.0%	29,985	12/31/2025
2025 Q3	11/10/2025	191	0.0%	44,989	9/30/2025
2025 Q1	9/15/2025	28	0.0%	22,913	3/31/2025
2024 Q4	2/6/2025	84	0.0%	65,073	12/31/2024
2024 Q3	11/12/2024	179	0.0%	65,073	9/30/2024
2024 Q2	8/12/2024	147	0.0%	65,073	6/30/2024
2024 Q1	5/9/2024	42	0.0%	17,413	3/31/2024
2023 Q4	2/6/2024	29	0.0%	17,413	12/31/2023
2023 Q3	11/8/2023	33	0.0%	17,413	9/30/2023
2023 Q2	8/10/2023	25	0.0%	17,413	6/30/2023
2023 Q1	5/12/2023	37	0.0%	17,413	3/31/2023
2022 Q4	2/13/2023	20	0.0%	17,413	12/31/2022
2022 Q3	11/14/2022	29	0.0%	17,413	9/30/2022
2022 Q2	8/15/2022	23	0.0%	17,413	6/30/2022
2022 Q1	5/13/2022	29	0.0%	17,413	3/31/2022
2021 Q4	2/11/2022	37	0.0%	17,413	12/31/2021
2021 Q3	11/16/2021	68	0.0%	17,413	9/30/2021
2021 Q2	8/16/2021	56	0.0%	17,413	6/30/2021
2021 Q1	5/17/2021	169	0.0%	77,488	3/31/2021
2020 Q4	2/16/2021	192	0.0%	85,501	12/31/2020
2020 Q3	11/13/2020	229	0.0%	85,501	9/30/2020
2020 Q2	8/20/2020	285	0.0%	92,939	6/30/2020
2020 Q1	5/15/2020	182	0.0%	92,444	3/31/2020
2019 Q4	2/7/2020	265	0.0%	92,444	12/31/2019
2014 Q2	7/30/2014	365	0.0%	26,400	6/30/2014